SynthesisJCO clinical cancer informatics2017

Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates.

Ehsan Malek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.